We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

Fund managers haven’t disclosed any holdings of OPTR yet.

OPTR Hedge Fund Activity: Q4 2013 in Review

0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q4 2013, worth a combined $0 — down 100% from $526M a quarter earlier.

Sellers outnumbered buyers: 103 funds closed out of OPTR and 0 opened new positions — a net loss of 103 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Water Island Capital, exiting entirely with an estimated $37M sold.

  • 0 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q4 2013, down from 104 in Q3 2013.
  • Funds reported $0 of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q4 2013 and 103 closed out, a net change of -103 holders.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q4 2013 was Water Island Capital, an estimated $37M sold.

Based on aggregated 13F filings for Q4 2013.